Clinical Trials Directory

Trials / Unknown

UnknownNCT05267847

The Success Rate of Cryotherapy Application in Primary Molars With Signs of Irreversible Pulpitis

The Success Rate of Cryotherapy Application in Primary Molars With Signs of Irreversible

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
188 (estimated)
Sponsor
Minia University · Academic / Other
Sex
All
Age
5 Years – 9 Years
Healthy volunteers
Accepted

Summary

The study is designed as a randomized controlled trial with two parallel groups. Children aged 5-9 years with primary molars from suffered symptomatic signs of irreversible pulpitis will be randomly assigned into two groups. The first group (experimental group) will be injected with 4% articaine 1:100.000 epinephrine (inferior alveolar nerve block). For the second group, the mandibular second primary molars will be anesthetized using 4% articaine 1:100.000 epinephrine using inferior alveolar nerve block.

Conditions

Interventions

TypeNameDescription
OTHERCryotherapylocal anesthetic injection with articaine 4% 1:100,000 epinephrine then an application ice packs
OTHERTraditional local anesthesialocal anesthetic injection with articaine 4% 1:100,000 epinephrine

Timeline

Start date
2022-02-22
Primary completion
2022-04-30
Completion
2022-04-30
First posted
2022-03-04
Last updated
2022-03-04

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05267847. Inclusion in this directory is not an endorsement.